Evaluation of Walk With Ease in Arthritis (WWE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00526435|
Recruitment Status : Completed
First Posted : September 10, 2007
Last Update Posted : March 24, 2011
|Condition or disease||Intervention/treatment||Phase|
|Arthritis||Behavioral: Walk with Ease - Group Behavioral: Walk with Ease - Self||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||468 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Investigator, Outcomes Assessor)|
|Official Title:||Evaluation of the Walk With Ease Program Among People With Arthritis|
|Study Start Date :||October 2007|
|Actual Primary Completion Date :||January 2010|
|Actual Study Completion Date :||January 2010|
Experimental: Group WWE
Subjects will participate in a group-assisted 6 week WWE program.
Behavioral: Walk with Ease - Group
Participate in 6-week, 1 hour per week group assisted classes (with instructor).
Subjects will follow the self-directed WWE program.
Behavioral: Walk with Ease - Self
SUbject will receive the WWE workbook and follow it without group/instructor assistance.
- Physical Activity Level [ Time Frame: 6 weeks ]
- 6-minute walk [ Time Frame: 6 weeks ]
- Walking behaviors [ Time Frame: 6 weeks ]
- Exercise self-efficacy [ Time Frame: 6 weeks ]
- Health-related Quality of Life (SF36)
- Health Assessment Questionnaire
- Arthritis Symptoms
- Senior Fitness Test (function)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00526435
|United States, North Carolina|
|University of North Carolina - Chapel Hill|
|Chapel Hill, North Carolina, United States, 27599|
|Study Director:||Jennifer M Hootman, PhD||Centers for Disease Control and Prevention|
|Principal Investigator:||Leigh F Callahan, PhD||University of North Carolina, Chapel Hill|